Market Research Logo

Insmed Incorporated (INSM) - Financial and Strategic SWOT Analysis Review

Insmed Incorporated (INSM) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Insmed Incorporated (Insmed) is a biopharmaceutical company which focuses on developing and commercializing drugs for the treatment of serious lung infections. The company’s lead product candidate, Arikace (liposomal amikacin for inhalation), is developed for nontuberculous mycobacteria (NTM) lung disease. Its clinical pipeline include INS1009, a nebulized prodrug formulation treats rare pulmonary disorders such as idiopathic pulmonary fibrosis (IPF) sarcoidosis, pulmonary arterial hypertension (PAH) and severe refractory asthma. The product candidate obtained orphan drug designation for Pseudomonas lung infections in CF patients in the US and Europe; and for NTM lung infections in the US. Insmed is headquartered in Bridgewater, New Jersey, the US.

Insmed Incorporated Key Recent Developments

May 05, 2016: Insmed Reports First Quarter 2016 Financial Results
Feb 25, 2016: Insmed Reports Fourth Quarter 2015 Financial Results
Nov 06, 2015: Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update
Aug 06, 2015: Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update
May 07, 2015: Insmed Reports First Quarter 2015 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Insmed Incorporated - Key Facts
Insmed Incorporated - Key Employees
Insmed Incorporated - Key Employee Biographies
Insmed Incorporated - Major Products and Services
Insmed Incorporated - Pharmaceutical Pipeline Products Data
Insmed Incorporated, Pipeline Products by Therapy Area
Insmed Incorporated, Pipeline Products by Development Phase
Insmed Incorporated - History
Insmed Incorporated - Company Statement
Insmed Incorporated - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Insmed Incorporated - Business Description
Insmed Incorporated - Corporate Strategy
Insmed Incorporated - SWOT Analysis
SWOT Analysis - Overview
Insmed Incorporated - Strengths
Strength - Focused Research and Development Activities
Strength - Patent Portfolio
Strength - Proprietary Liposomal Technology
Insmed Incorporated - Weaknesses
Weakness - Lack of Product Based Revenues
Weakness - Competitive Positioning
Weakness - Clinical Results
Insmed Incorporated - Opportunities
Opportunity - Biotechnology Focus
Opportunity - Arikace - Orphan Drug Status
Opportunity - Market Potential: Cystic Fibrosis
Insmed Incorporated - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Insmed Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Insmed Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 05, 2016: Insmed Reports First Quarter 2016 Financial Results
Feb 25, 2016: Insmed Reports Fourth Quarter 2015 Financial Results
Nov 06, 2015: Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update
Aug 06, 2015: Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update
May 07, 2015: Insmed Reports First Quarter 2015 Financial Results
Feb 27, 2015: Insmed Reports 2014 Fourth Quarter and Full Year Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Insmed Incorporated, Key Facts
Insmed Incorporated, Key Employees
Insmed Incorporated, Key Employee Biographies
Insmed Incorporated, Major Products and Services
Insmed Incorporated, Number of Pipeline Products by Therapy Area
Insmed Incorporated, Number of Pipeline Products by Development Stage
Insmed Incorporated, Pipeline Products By Therapy Area and Development Phase
Insmed Incorporated, History
Insmed Incorporated, Subsidiaries
Insmed Incorporated, Key Competitors
Insmed Incorporated, Ratios based on current share price
Insmed Incorporated, Annual Ratios
Insmed Incorporated, Interim Ratios
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Insmed Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Insmed Incorporated, Pipeline Products by Therapy Area
Insmed Incorporated, Pipeline Products by Development Phase
Insmed Incorporated, Performance Chart (2011 - 2015)
Insmed Incorporated, Ratio Charts
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Insmed Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report